Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MultiPepT1De in Recent Onset Type 1 Diabetes
NCT02620332Phase 1Completed
- Sponsor
- King's College London
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MultiPepT1De in type 1 diabetes mellitus (T1D) (4 arms), sponsored by King's College London. Primary endpoint: Assessment of MultiPepT1De safety profile at 147 days. Started Oct 2015; status: completed.
02
Drugs
MultiPepT1De
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02620332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620332.